Title : Metabolism of the immunosuppressant tacrolimus in the small intestine: cytochrome P450, drug interactions, and interindividual variability.

Pub. Date : 1995 Dec

PMID : 8689938






6 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The metabolism of tacrolimus by human small intestine was inhibited by anti-CYP3A, troleandomycin, and erythromycin, indicating that, as in the liver, CYP3A enzymes are the major enzymes for tacrolimus metabolism in the human small intestine. Tacrolimus cytochrome P450 family 3 subfamily A member 4 Homo sapiens
2 The metabolism of tacrolimus by human small intestine was inhibited by anti-CYP3A, troleandomycin, and erythromycin, indicating that, as in the liver, CYP3A enzymes are the major enzymes for tacrolimus metabolism in the human small intestine. Tacrolimus cytochrome P450 family 3 subfamily A member 4 Homo sapiens
3 The metabolism of tacrolimus by human small intestine was inhibited by anti-CYP3A, troleandomycin, and erythromycin, indicating that, as in the liver, CYP3A enzymes are the major enzymes for tacrolimus metabolism in the human small intestine. Tacrolimus cytochrome P450 family 3 subfamily A member 4 Homo sapiens
4 The metabolism of tacrolimus by human small intestine was inhibited by anti-CYP3A, troleandomycin, and erythromycin, indicating that, as in the liver, CYP3A enzymes are the major enzymes for tacrolimus metabolism in the human small intestine. Tacrolimus cytochrome P450 family 3 subfamily A member 4 Homo sapiens
5 It is concluded that tacrolimus is metabolized by cytochrome CYP3A enzymes in the small intestine. Tacrolimus cytochrome P450 family 3 subfamily A member 4 Homo sapiens
6 The rate of the CYP3A enzymatic activities varies about 5 times from patient to patient, and drugs that interfere with the in vitro metabolism of tacrolimus in the liver also inhibit its small intestinal metabolism. Tacrolimus cytochrome P450 family 3 subfamily A member 4 Homo sapiens